What’s the move ?
since Eli Lilly’s buyout of AtaiBeckley, it feels like this Psychedelic industry might finally be up to bat. I’ve been following MAPS -Rick Doblin for 10+ years since I was in college, long before any of this was getting mainstream attention. Whether it’s psilocybin, MDMA, LSD, ketamine, DMT, ibogaine, or ayahuasca, I’ve always believed these are eventually going to change the way we treat ourselves. Obviously they’re all different compounds with different regulatory paths, but I think the overall direction is pretty clear. I don’t own any stocks yet, but I’m looking to change that. I’ve got a good bit of capital I’d like to invest over the long term and this is an industry I believe could grow into something massive. So for those of you who’ve been following: What companies are you buying and holding? Which ones have the strongest pipeline or best chance of actually making it to market? Are there any smaller companies that aren’t getting much attention but could end up being major pla
Why it matters: RSS-imported item, awaiting editor or agent follow-up on market impact.